Coverage
-
October 30, 2014
A Delaware federal judge invalidated part of a DNA technology patent Genetic Technologies Ltd. accused Bristol-Myers Squibb Co. and a Sanofi-Aventis SA unit of infringing because it merely described a natural law, dooming the claim under the U.S. Supreme Court's landmark Mayo v. Prometheus decision.
1 other articles on this case.
View all »